COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the acquisition of the "Drug GMP Certificate" by wholly-owned subsidiari
Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-027
Jilin Zixin Pharmaceutical Co., Ltd.
Announcement on the receipt of the "Drug GMP Certificate" by wholly-owned subsidiaries
In accordance with the provisions of the State Food and Drug Administration, "Administrative Measures for the Administration of Pharmaceutical Production Quality Management Standards", Jilin Zixin Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Jilin Zixin Pharmaceutical Co., Ltd., has been approved by the Jilin Food and Drug Administration for on-site inspection and approval. Industry Co., Ltd. (hereinafter referred to as “Bairuo Pharmaceutical”) meets the requirements of “Good Manufacturing Practices (2010 Revision)” and has obtained the new version of “Pharmaceutical GMP Certificate” issued by Jilin Food and Drug Administration (Certificate No.: JL20130022) The Prajna Pharmaceutical Pill Workshop passed the new national GMP certification. The certification details are as follows:
Company Name: Jilin Zixin Prajna Pharmaceutical Co., Ltd.
Address: West Point Street, Lanshi Economic Development Zone, Jilin Province
Certification scope: Pills (Honey Pills, Water Pills, Water Pills, Concentrated Pills)
Valid until: June 20, 2018
Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors
June 26, 2013